{
  "id": 8889936,
  "title": "Pharma: Novo Nordisk peilt bis 2030 fünf neue Blockbuster-Medikamente an – Anleger enttäuscht",
  "url": "https://urgent.news/2026/09/21/pharma-novo-nordisk-peilt-bis-2030-funf-neue-blockbuster-medikamente",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-21T08:49:39.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/pharma-novo-nordisk-peilt-bis-2030-fuenf-neue-blockbuster-medikamente-an/100256134.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Der Pharmakonzern plant zudem, die Produktion von Abnehmtabletten deutlich auszubauen. Künftig sollen weltweit mehr als 60 Millionen Patienten behandelt werden. Die Aktie fällt.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Another Novartis failure; Novo drops the ‘Nordisk’; and more",
        "url": "https://urgent.news/2026/09/19/another-novartis-failure-novo-drops-the-nordisk-and-more",
        "published": "2026-09-19T10:00:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}